Ying Chang

1.1k total citations · 1 hit paper
6 papers, 490 citations indexed

About

Ying Chang is a scholar working on Infectious Diseases, Animal Science and Zoology and Immunology. According to data from OpenAlex, Ying Chang has authored 6 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Animal Science and Zoology and 3 papers in Immunology. Recurrent topics in Ying Chang's work include SARS-CoV-2 and COVID-19 Research (4 papers), Animal Virus Infections Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). Ying Chang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Animal Virus Infections Studies (3 papers) and Immunotherapy and Immune Responses (2 papers). Ying Chang collaborates with scholars based in United States, China and United Kingdom. Ying Chang's co-authors include Bethany Girard, Jacqueline M. Miller, Darin K. Edwards, Rituparna Das, David C. Montefiori, Lindsey R. Baden, Spyros Chalkias, Brandon Essink, Keith Vrbicky and Jing Feng and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Ying Chang

6 papers receiving 478 citations

Hit Papers

A Bivalent Omicron-Containing Booster Vaccine against Cov... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Chang United States 5 442 107 97 91 72 6 490
Adam Brosz United States 4 363 0.8× 89 0.8× 78 0.8× 79 0.9× 54 0.8× 4 399
Nichole McGhee United States 3 357 0.8× 88 0.8× 76 0.8× 79 0.9× 54 0.8× 3 393
Alina Seidel Germany 8 679 1.5× 146 1.4× 109 1.1× 68 0.7× 78 1.1× 12 736
Andrea Sutherland United States 2 322 0.7× 84 0.8× 66 0.7× 70 0.8× 52 0.7× 2 357
Justin DaSilva United States 5 509 1.2× 121 1.1× 71 0.7× 101 1.1× 58 0.8× 6 598
Bethany Girard United States 9 590 1.3× 130 1.2× 120 1.2× 120 1.3× 111 1.5× 24 694
Ann-Kathrin Wallisch Germany 4 671 1.5× 175 1.6× 91 0.9× 108 1.2× 103 1.4× 4 713
Gina S. Lee United States 9 491 1.1× 86 0.8× 64 0.7× 190 2.1× 43 0.6× 14 547

Countries citing papers authored by Ying Chang

Since Specialization
Citations

This map shows the geographic impact of Ying Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Chang more than expected).

Fields of papers citing papers by Ying Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Chang. The network helps show where Ying Chang may publish in the future.

Co-authorship network of co-authors of Ying Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Chang. A scholar is included among the top collaborators of Ying Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Chang. Ying Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Chalkias, Spyros, Charles Harper, Keith Vrbicky, et al.. (2023). Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19. Nature Communications. 14(1). 5125–5125. 11 indexed citations
3.
Chang, Ying, et al.. (2022). Cytomegalovirus Proctitis Developed after COVID-19 Vaccine: A Case Report and Literature Review. Vaccines. 10(9). 1417–1417. 5 indexed citations
4.
Chalkias, Spyros, Frank Eder, Brandon Essink, et al.. (2022). Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial. Nature Medicine. 28(11). 2388–2397. 70 indexed citations
5.
Chu, Laurence, Keith Vrbicky, David C. Montefiori, et al.. (2022). Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial. Nature Medicine. 28(5). 1042–1049. 56 indexed citations
6.
Chalkias, Spyros, Charles Harper, Keith Vrbicky, et al.. (2022). A Bivalent Omicron-Containing Booster Vaccine against Covid-19. New England Journal of Medicine. 387(14). 1279–1291. 346 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026